4.72
price up icon0.43%   0.02
after-market アフターアワーズ: 4.61 -0.11 -2.33%
loading
前日終値:
$4.70
開ける:
$4.59
24時間の取引高:
70,550
Relative Volume:
0.29
時価総額:
$3.21M
収益:
$12.99M
当期純損益:
$-23.72M
株価収益率:
-0.0485
EPS:
-97.2514
ネットキャッシュフロー:
$-23.28M
1週間 パフォーマンス:
-14.31%
1か月 パフォーマンス:
-58.30%
6か月 パフォーマンス:
-97.72%
1年 パフォーマンス:
-99.12%
1日の値動き範囲:
Value
$4.5308
$4.9299
1週間の範囲:
Value
$4.30
$5.50
52週間の値動き範囲:
Value
$4.30
$658.60

Aptevo Therapeutics Inc Stock (APVO) Company Profile

Name
名前
Aptevo Therapeutics Inc
Name
セクター
Healthcare (1170)
Name
電話
206-838-0500
Name
住所
2401 4TH AVE., SEATTLE, WA
Name
職員
37
Name
Twitter
@aptevo
Name
次回の収益日
2024-11-12
Name
最新のSEC提出書
Name
APVO's Discussions on Twitter

APVO を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
APVO
Aptevo Therapeutics Inc
4.72 185.90K 12.99M -23.72M -23.28M -97.25
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

Aptevo Therapeutics Inc Stock (APVO) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2018-11-05 開始されました Ladenburg Thalmann Buy
2017-10-05 再開されました Piper Jaffray Overweight

Aptevo Therapeutics Inc (APVO) 最新ニュース

pulisher
May 29, 2025

Aptevo Therapeutics Inc. (NASDAQ:APVO) Sees Large Decrease in Short Interest - Defense World

May 29, 2025
pulisher
May 25, 2025

Aptevo Therapeutics (APVO) Trading Suspended as News Awaits | AP - GuruFocus

May 25, 2025
pulisher
May 23, 2025

Aptevo Therapeutics (APVO) Trading Suspended as News Awaits | APVO Stock News - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Aptevo Therapeutics Approves 1-for-20 Reverse Stock Split - TipRanks

May 23, 2025
pulisher
May 22, 2025

Aptevo Therapeutics Announces Reverse Stock Split - TipRanks

May 22, 2025
pulisher
May 22, 2025

Aptevo Therapeutics to Implement 1-for-20 Reverse Stock Split - marketscreener.com

May 22, 2025
pulisher
May 22, 2025

Aptevo Therapeutics Announces 1-for-20 Reverse Stock Split as pa - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Aptevo Therapeutics (APVO) Announces 1-for-20 Reverse Stock Split | APVO Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Aptevo Therapeutics enacts reverse stock split to maintain Nasdaq compliance - Investing.com

May 22, 2025
pulisher
May 22, 2025

Aptevo Therapeutics Announces 1-for-20 Reverse Stock Split as part of Nasdaq Compliance Plan - ACCESS Newswire

May 22, 2025
pulisher
May 22, 2025

Aptevo's Dramatic 1:20 Reverse Split Cuts Shares from 13.5M to 0.7M in Nasdaq Compliance Push - Stock Titan

May 22, 2025
pulisher
May 18, 2025

StockNews.com Begins Coverage on Aptevo Therapeutics (NASDAQ:APVO) - Defense World

May 18, 2025
pulisher
May 16, 2025

Aptevo Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 16, 2025
pulisher
May 15, 2025

Aptevo reports high remission in AML patients with new drug By Investing.com - Investing.com South Africa

May 15, 2025
pulisher
May 15, 2025

APVO: Promising Trial Results Propel AML Treatment Innovations | - GuruFocus

May 15, 2025
pulisher
May 15, 2025

APVO: Promising Trial Results Propel AML Treatment Innovations | APVO Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Aptevo reports high remission in AML patients with new drug - Investing.com Australia

May 15, 2025
pulisher
May 15, 2025

Aptevo Therapeutics Reports 1Q25 Financial Results And Provides an Update on Mipletamig | APVO Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Aptevo Therapeutics Reports 1Q25 Financial Results And Provides an Update on Mipletamig - ACCESS Newswire

May 15, 2025
pulisher
May 14, 2025

Breakthrough: New AML Drug Shows 90% Remission Rate With Zero Cytokine Release Syndrome - Stock Titan

May 14, 2025
pulisher
May 12, 2025

Aptevo Therapeutics (APVO) Expected to Announce Earnings on Wednesday - Defense World

May 12, 2025
pulisher
May 10, 2025

Aptevo Therapeutics (NASDAQ:APVO) Now Covered by Analysts at StockNews.com - Defense World

May 10, 2025
pulisher
May 08, 2025

Aptevo Therapeutics Announces $3.0 Million Offering Priced At-the-Market Under Nasdaq Rules - ACCESS Newswire

May 08, 2025
pulisher
May 08, 2025

Aptevo Therapeutics Provides Program Update for Bispecific APVO7 - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Aptevo Therapeutics Says In Preclinical Studies APVO711 Demonstrates Dual Anti-Cancer Functionality - marketscreener.com

May 08, 2025
pulisher
May 08, 2025

Aptevo Therapeutics (APVO) Advances Innovative Immunotherapy wit - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Aptevo Therapeutics (APVO) Advances Innovative Immunotherapy with APVO711 Update | APVO Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Aptevo Therapeutics Provides Program Update for Bispecific APVO711, a PD-L1 X CD40 that Combines a Checkpoint Inhibitor and Immune Activation | APVO Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Aptevo Therapeutics Provides Program Update for Bispecific APVO711, a PD-L1 X CD40 that Combines a Checkpoint Inhibitor and Immune Activation - ACCESS Newswire

May 08, 2025
pulisher
May 01, 2025

Aptevo Therapeutics announces common stock offering - Investing.com Australia

May 01, 2025
pulisher
Apr 30, 2025

APVO’s latest rating updates from top analysts. - knoxdaily.com

Apr 30, 2025
pulisher
Apr 30, 2025

Strategic Moves Drive Stock Gains For OSR, Lianhe Sowell, And Aptevo - Finimize

Apr 30, 2025
pulisher
Apr 29, 2025

Aptevo Therapeutics announces common stock offering By Investing.com - Investing.com Canada

Apr 29, 2025
pulisher
Apr 29, 2025

Closing Bell Recap: Aptevo Therapeutics Inc (APVO) Ends at 0.61, Reflecting a -9.31 Downturn - DWinneX

Apr 29, 2025
pulisher
Apr 29, 2025

Aptevo Therapeutics announces at-the-market offering - Investing.com Australia

Apr 29, 2025
pulisher
Apr 28, 2025

APVO stock plunges to 52-week low, touches $0.59 - Investing.com

Apr 28, 2025
pulisher
Apr 28, 2025

APVO stock plunges to 52-week low, touches $0.59 By Investing.com - Investing.com UK

Apr 28, 2025
pulisher
Apr 28, 2025

Aptevo Therapeutics announces at-the-market offering By Investing.com - Investing.com India

Apr 28, 2025
pulisher
Apr 28, 2025

SEC Form 424B4 filed by Aptevo Therapeutics Inc. - Quantisnow

Apr 28, 2025
pulisher
Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025
pulisher
Apr 26, 2025

Aptevo Therapeutics Inc. Announces Pricing of $5 Million Public Offering - ACCESS Newswire

Apr 26, 2025
pulisher
Apr 25, 2025

Aptevo Therapeutics Announces Exercise of Warrants for $6.2 Million Gross Proceeds - ACCESS Newswire

Apr 25, 2025
pulisher
Apr 25, 2025

Applied Materials Q2 Earnings: Tech Giant's Financial Results Coming May 15 - Stock Titan

Apr 25, 2025
pulisher
Apr 24, 2025

A look into Aptevo Therapeutics Inc (APVO)’s deeper side - Sete News

Apr 24, 2025
pulisher
Apr 23, 2025

Aptevo Therapeutics Inc’s latest rating changes from various analysts - knoxdaily.com

Apr 23, 2025
pulisher
Apr 23, 2025

Evogene (EVGN) Sees Dramatic Surge in Investor Interest Amid Strategic Moves | APVO Stock News - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

Market Momentum: Aptevo Therapeutics Inc (APVO) Registers a 9.08 Increase, Closing at 0.69 - DWinneX

Apr 23, 2025

Aptevo Therapeutics Inc (APVO) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
大文字化:     |  ボリューム (24 時間):